Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT05735067
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 50 years at time of signing informed consent form.
* Relapsing- remitting multiple sclerosis as per the McDonald 2017 criteria, including an MRI brain satisfying the 2017 radiological criteria.
* Kurtzke EDSS step 0.0 - 6.0.
* At the time of screening, being treated with a stable dose of Interferon Beta 1a for at least 6 months.
Exclusion Criteria:
* they had been treated in the last 30 days with methylprednisolone
* they had changed their IFN-β preparation within the last 18 months
* they had other chronic diseases associated with MS
* they had been previously treated with immunosuppressive agents
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT05735067
Study Brief:
Protocol Section:
NCT05735067